Material Data Sheet

Human SUMO1, MAb

Price: $229.00
Catalog #: A-716
Human SUMO1, MAb
100 μg
Data Sheet: 
Small Ubiquitin­like Modifiers (SUMOs) are a family of small, related proteins that can be enzymatically attached to a target protein by a post­translational modification process termed SUMOylation. Unlike ubiquitination, which targets proteins for degradation, SUMOylation participates in a number of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. All human SUMO proteins share a conserved ubiquitin-like domain and a C-terminal diglycine cleavage/attachment site. Human SUMO1, also known as Sentrin, UBL1, and SMT3C, is synthesized as a 101 amino acid (aa) propeptide that contains a four aa C­terminal prosegment. Following prosegment cleavage, the C­terminal glycine may be enzymatically attached to a lysine on a target protein. Human SUMO1 shares 100% sequence identity to SUMO1 from mouse. SUMO1 is the most unique of the four identified SUMO proteins and shares only 44%, 47%, and 41% sequence identity to SUMO2, SUMO3, and SUMO4, respectively.

Product Information

0.5 mg/mL in PBS, pH 7.4, 50% glycerol, 0.09% sodium azide
IgG2A. Clone # 852620
Purified, recombinant human SUMO1. Accession Number P63165

Use & Storage

Recommended concentration for Western Blot is 0.1 - 0.5 µg/ml.
Store at -20°C.
This antibody detects endogenous, human SUMOylated proteins in Western blots. It shows no cross-reactivity against recombinant SUMO2, SUMO3, and SUMO4 in Western blots.